Signal Transduction Pathways, Part B
Stress Signaling and Transcriptional Control, Volume 1091
Herausgeber: Diederich, Marc
Signal Transduction Pathways, Part B
Stress Signaling and Transcriptional Control, Volume 1091
Herausgeber: Diederich, Marc
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This is the second volume to emerge from the cell signaling meeting in Luxembourg (see Part A) to discuss therapeutic applications in the field of signal transduction, transcription, and translation. These meetings and the volumes comprising their proceedings have brought forward new insights in this rapidly moving field. These volumes focus on the therapeutic potential for targeting cell signaling mechanisms with particular attention to cancer therapies and inflammatory signaling pathways as well as immunomodulation. Part B focuses on basic research, and the chapters are divided into the…mehr
- Marc DiederichSignal Transduction Pathways, Part a200,99 €
- Rakesh Kumar (ed.)Molecular Targeting and Signal Transduction192,99 €
- Walter PierpaoliReversal of Aging178,99 €
- ljsbrand M. KramerSignal Transduction120,99 €
- Molecular Biology of Cancer 2e120,99 €
- Applications of Flow Cytometry in Stem Cell Research and Tissue Regeneration197,99 €
- Ari SitaramayyaSignal Transduction80,99 €
-
-
-
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Produktdetails
- Verlag: Wiley
- Seitenzahl: 400
- Erscheinungstermin: 14. Mai 2007
- Englisch
- Abmessung: 230mm x 154mm x 23mm
- Gewicht: 962g
- ISBN-13: 9781573316477
- ISBN-10: 1573316474
- Artikelnr.: 24827506
- Verlag: Wiley
- Seitenzahl: 400
- Erscheinungstermin: 14. Mai 2007
- Englisch
- Abmessung: 230mm x 154mm x 23mm
- Gewicht: 962g
- ISBN-13: 9781573316477
- ISBN-10: 1573316474
- Artikelnr.: 24827506
guez, Nerea Bartolome, Begona Ochoa, and Mar
a J. Mart
nez. 27. The cAMP-Responsive Unit of the Human Insulin-Like Growth Factor-Binding Protein-1 Coinstitutes a Functional Insulin-Response Element: Ghislaine Schweizer-Groyer, Guillaume Fallot, Francoise Cadepond, Christelle Girard, and Andre Groyer. 28. c-Jun and JunB Are Essential for Hypoglycemia-Mediated VEGF Induction: Bjorn Textor, Melanie Sator-Schmitt, Karl Hartmut Richter, Peter Angel, and Marina Schorpp-Kistner. 29. Altered Gene Expression Pattern in Peripheral Blood Leukocytes from Patients with Arterial Hypertension: A.V. Timofeeva, L.E. Goryunova, G.L. Khaspekov, D.A. Kovalevskii, A.V. Scamrov, O.S. Bulkina, Yu.A. Karpov, K.A. Talitskii, V.V. Buza, V.V. Britareva, and R.Sh. Beabealashvilli. 30. Effects of AT1 Receptor-Mediated Endocytosis of Extracellular Ang II on Activation of Nuclear Factor-_B in Proximal Tubule Cells: Jia L. Zhuo, Oscar A. Carretero, and Xiao C. Li. Part III: Histone Deacetylase:. 31. Retinoic Acid and Histone Deacetylase Inhibitor BML-210 Inhibit Proliferation of Human Cervical Cancer HeLa Cells: Veronika V. Borutinskaite, Ruta Navakauskiene, and Karl-Eric Magnusson. 32. Effects of Histone Deacetylase Inhibitors, Sodium Phenyl Butyrate, and Vitamin B3, in Combination with Retinoic Acid, on Granulocytic Differentiation of Human Promyelocytic Leukemia HL-60 Cells: Rasa Merzvinskyte, Grazina Treigyte, Jurate Savickiene, Karl-Eric Magnusson, and Ruta Navakauskiene. 33. The Histone Deacetylase Inhibitor FK228 Distinctly Sensitizes the Human Leukemia Cells to Retinoic Acid-Induced Differentiation: Jurate Savickiene, Grazina Treigyte, Veronika Borutinskaite, Ruta Navakauskiene, and Karl-Eric Magnusson. 34. Effect of Valproic Acid, a Histone Deacetylase Inhibitor, on Cell Death and Molecular Changes Caused by Low-Dose Irradiation: Darina Zaskodova, Martina Rezacova, Jirina Vavrova, Doris Vokurkova, and Ales Tichy. Part IV: Novel Technological and Therapeutical Approaches:. 35. Protein Folding Information in Nucleic Acids Which Is Not Present in the Genetic Code: Jan C. Biro. 36. Antigens and Cytokine Genes in Antitumor Vaccines: The Importance of the Temporal Delivery Sequence in Antitumor Signals: Maria Jose Herrero, Rafael Botella, Francisco Dasi, Rosa Algas, Maria Sanchez, and Salvador F. Alino. 37. Arrest of Cancer Cell Proliferation by dsRNAs: Tatyana O. Kabilova, A`Lbina V. Vladimirova, Elena L. Chernolovskaya, and Valentin V. Vlassov. 38. Design and Functional Activity of Phosphopeptides with Potential Immunomodulating Capacity, Based on the Sequence of Grb2-Associated Binder 1: Akos Kertesz, Balazs Takacs, Gyorgyi Varadi, Gabor K. Toth, and Gabriella Sarmay. 39. Distinct Activity of Peptide Mimetic Intracellular Ligands (Pepducins) for Proteinase-Activated Receptor-1 in Multiple Cells/Tissues: Satoko Kubo, Tsuyoshi Ishiki, Ichiko Doe, Fumiko Sekiguchi, Hiroyuki Nishikawa, Kenzo Kawai, Hirofumi Matsui, and Atsufumi Kawabata. 40. A New Method to Assess Drug Sensitivity on Breast Tumor Acute Slices Preparation: Pedro Mestres, Andrea Morguet, Werner Schmidt, Axel Kob, and Elke Thedinga. 41. Process Simulation in a Mechatronic Bioreactor Device with Speed-Regulated Motors for Growing of Three-Dimensional Cell Cultures: Mina Mihailova, Vassil Trenev, Penka Genova, and Spiro Konstantinov. 42. Animal Model of Drug-Resistant Tumor Progression: Nadezda Mironova, Olga Shklyaeva, Ekaterina Andreeva, Nelly Popova, Vasilyi Kaledin, Valeryi Nikolin, Valentin Vlassov, and Marina Zenkova. 43. Preparation and Characterization of Recombinant Chicken Growth Hormone (chGH) and Its Putative Antagonist chGH G119R Mutein: Helena E. Paczoska-Eliasiewicz, Gili Salomon, Shay Reicher, Eugene E. Gussakowsky, Anna Hrabia, and Arieh Gertler. 44. Induction of Apoptosis of Osteoclasts by Targeting Transcription Factors with Decoy Molecules: Roberta Piva, Letizia Penolazzi, Margherita Zennaro, Ercolina Bianchini, Eros Magri, Monica Borgatti, Ilaria Lampronti, Elisabetta Lambertini, Elisa Tavanti, and Roberto Gambari. 45. Competition Effects Shape the Response Sensitivity and Kinetics of Phosphorylation Cycles in Cell Signaling: Carlos Salazar and Thomas Hofer. 46. Preparation of Leptin Antagonists by Site-Directed Mutagenesis of Human, Ovine, Rat, and Mouse Leptin's Site III: Implications on Blocking Undesired Leptin Action In Vivo: Gili Solomon, Leonora Niv-Spector, Dana Gonen-Berger, Isabelle Callebaut, Jean Djiane, and Arieh Gertler. 47. Dual Activity of Phosphorothioate CpG Oligodeoxynucleotides on HIV: Reactivation of Latent Provirus and Inhibition of Productive Infection in Human T Cells: Carsten Scheller, Anett Ullrich, Stefan Lamla, Ulf Dittmer, Axel Rethwilm, and Eleni Koutsilieri. 48. Prostanoids with Cyclopentenone Structure as Tools for the Characterization of Electrophilic Lipid-Protein Interactomes: Konstantinos Stamatakis and Dolores Perez-Sala. Index of Contributors
guez, Nerea Bartolome, Begona Ochoa, and Mar
a J. Mart
nez. 27. The cAMP-Responsive Unit of the Human Insulin-Like Growth Factor-Binding Protein-1 Coinstitutes a Functional Insulin-Response Element: Ghislaine Schweizer-Groyer, Guillaume Fallot, Francoise Cadepond, Christelle Girard, and Andre Groyer. 28. c-Jun and JunB Are Essential for Hypoglycemia-Mediated VEGF Induction: Bjorn Textor, Melanie Sator-Schmitt, Karl Hartmut Richter, Peter Angel, and Marina Schorpp-Kistner. 29. Altered Gene Expression Pattern in Peripheral Blood Leukocytes from Patients with Arterial Hypertension: A.V. Timofeeva, L.E. Goryunova, G.L. Khaspekov, D.A. Kovalevskii, A.V. Scamrov, O.S. Bulkina, Yu.A. Karpov, K.A. Talitskii, V.V. Buza, V.V. Britareva, and R.Sh. Beabealashvilli. 30. Effects of AT1 Receptor-Mediated Endocytosis of Extracellular Ang II on Activation of Nuclear Factor-_B in Proximal Tubule Cells: Jia L. Zhuo, Oscar A. Carretero, and Xiao C. Li. Part III: Histone Deacetylase:. 31. Retinoic Acid and Histone Deacetylase Inhibitor BML-210 Inhibit Proliferation of Human Cervical Cancer HeLa Cells: Veronika V. Borutinskaite, Ruta Navakauskiene, and Karl-Eric Magnusson. 32. Effects of Histone Deacetylase Inhibitors, Sodium Phenyl Butyrate, and Vitamin B3, in Combination with Retinoic Acid, on Granulocytic Differentiation of Human Promyelocytic Leukemia HL-60 Cells: Rasa Merzvinskyte, Grazina Treigyte, Jurate Savickiene, Karl-Eric Magnusson, and Ruta Navakauskiene. 33. The Histone Deacetylase Inhibitor FK228 Distinctly Sensitizes the Human Leukemia Cells to Retinoic Acid-Induced Differentiation: Jurate Savickiene, Grazina Treigyte, Veronika Borutinskaite, Ruta Navakauskiene, and Karl-Eric Magnusson. 34. Effect of Valproic Acid, a Histone Deacetylase Inhibitor, on Cell Death and Molecular Changes Caused by Low-Dose Irradiation: Darina Zaskodova, Martina Rezacova, Jirina Vavrova, Doris Vokurkova, and Ales Tichy. Part IV: Novel Technological and Therapeutical Approaches:. 35. Protein Folding Information in Nucleic Acids Which Is Not Present in the Genetic Code: Jan C. Biro. 36. Antigens and Cytokine Genes in Antitumor Vaccines: The Importance of the Temporal Delivery Sequence in Antitumor Signals: Maria Jose Herrero, Rafael Botella, Francisco Dasi, Rosa Algas, Maria Sanchez, and Salvador F. Alino. 37. Arrest of Cancer Cell Proliferation by dsRNAs: Tatyana O. Kabilova, A`Lbina V. Vladimirova, Elena L. Chernolovskaya, and Valentin V. Vlassov. 38. Design and Functional Activity of Phosphopeptides with Potential Immunomodulating Capacity, Based on the Sequence of Grb2-Associated Binder 1: Akos Kertesz, Balazs Takacs, Gyorgyi Varadi, Gabor K. Toth, and Gabriella Sarmay. 39. Distinct Activity of Peptide Mimetic Intracellular Ligands (Pepducins) for Proteinase-Activated Receptor-1 in Multiple Cells/Tissues: Satoko Kubo, Tsuyoshi Ishiki, Ichiko Doe, Fumiko Sekiguchi, Hiroyuki Nishikawa, Kenzo Kawai, Hirofumi Matsui, and Atsufumi Kawabata. 40. A New Method to Assess Drug Sensitivity on Breast Tumor Acute Slices Preparation: Pedro Mestres, Andrea Morguet, Werner Schmidt, Axel Kob, and Elke Thedinga. 41. Process Simulation in a Mechatronic Bioreactor Device with Speed-Regulated Motors for Growing of Three-Dimensional Cell Cultures: Mina Mihailova, Vassil Trenev, Penka Genova, and Spiro Konstantinov. 42. Animal Model of Drug-Resistant Tumor Progression: Nadezda Mironova, Olga Shklyaeva, Ekaterina Andreeva, Nelly Popova, Vasilyi Kaledin, Valeryi Nikolin, Valentin Vlassov, and Marina Zenkova. 43. Preparation and Characterization of Recombinant Chicken Growth Hormone (chGH) and Its Putative Antagonist chGH G119R Mutein: Helena E. Paczoska-Eliasiewicz, Gili Salomon, Shay Reicher, Eugene E. Gussakowsky, Anna Hrabia, and Arieh Gertler. 44. Induction of Apoptosis of Osteoclasts by Targeting Transcription Factors with Decoy Molecules: Roberta Piva, Letizia Penolazzi, Margherita Zennaro, Ercolina Bianchini, Eros Magri, Monica Borgatti, Ilaria Lampronti, Elisabetta Lambertini, Elisa Tavanti, and Roberto Gambari. 45. Competition Effects Shape the Response Sensitivity and Kinetics of Phosphorylation Cycles in Cell Signaling: Carlos Salazar and Thomas Hofer. 46. Preparation of Leptin Antagonists by Site-Directed Mutagenesis of Human, Ovine, Rat, and Mouse Leptin's Site III: Implications on Blocking Undesired Leptin Action In Vivo: Gili Solomon, Leonora Niv-Spector, Dana Gonen-Berger, Isabelle Callebaut, Jean Djiane, and Arieh Gertler. 47. Dual Activity of Phosphorothioate CpG Oligodeoxynucleotides on HIV: Reactivation of Latent Provirus and Inhibition of Productive Infection in Human T Cells: Carsten Scheller, Anett Ullrich, Stefan Lamla, Ulf Dittmer, Axel Rethwilm, and Eleni Koutsilieri. 48. Prostanoids with Cyclopentenone Structure as Tools for the Characterization of Electrophilic Lipid-Protein Interactomes: Konstantinos Stamatakis and Dolores Perez-Sala. Index of Contributors